NovaBay Pharmaceuticals Reports Second Quarter 2017 Financial Results
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for lid and lash hygiene in the domestic eye care market, reports financial results for the three and six months ended June 30, 2017 and provides a business update. “We had record Avenova unit volume through the pharmacy channel during the second quarter, along with an 80% increase in revenue through this channel over the prior year.